EXEL 8-K 2026-09-11

EXELIXIS, INC. (EXEL) 8-K dated 2026-09-11 — accession 0000939767-26-000108. This URL is the filing, not the EXEL hub.

EXELIXIS, INC. (EXEL) is a biotechnology company listed on US.

EXELIXIS, INC. filed a 8-K on 2026-09-11. Accession 0000939767-26-000108.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EXEL revenue for 2026-01-02 was $2.32B. Net income was $782.6M. Revenue was up 7.0% from 2025-01-03 to 2026-01-02. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.

Not investment advice. The EXEL SEC hub lists recent forms. The stock page is the research view.